Evaluation of a wearable defibrillator for sudden cardiac arrest

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the effectiveness of the ASSURE wearable cardioverter defibrillator through active surveillance of real-world data collected in the ASSURE Patient Registry. It focuses on analyzing outcomes based on data recorded by the device and annotated by clinical experts in electrophysiology. The study aims to gather insights into the device's performance and its impact on patient safety and health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patient prescribed the ASSURE wearable cardioverter defibrillator
* Provided written informed consent to participate in the ASSURE Patient Registry

Exclusion Criteria:

* Patients who do not meet the Inclusion criteria

Where it's running

• University of Washington Medical Center
  Seattle, Washington, United States Recruiting

Study contacts

• Principal investigator: Jeanne Poole, M.D. — University of Washington
• Study coordinator: Kristin Eis, BSChE, MBA
• Email: kristin.eis@kestramedical.com
• Phone: 14256547596

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prehospital femoral arterial access to monitor blood pressure during OHCA

  This pilot study tests whether placing a femoral arterial sheath before hospital arrival is feasible and safe in adults with non-traumatic OHCA to enable invasive blood pressure monitoring and better vasopressor control.

  Recruiting Emergency Medical Service, Prague · Prague · NCT07596446

• Predicting sudden cardiac arrest risk in people with coronary artery disease

  This project will try to see if combining genetics, ECGs, blood biomarkers, imaging, and psychosocial information can predict which people with coronary artery disease are most likely to have sudden cardiac arrest.

  Recruiting at 3 sites Tampere Heart Hospital · Hadera and 2 other locations · NCT07444931

• Identifying risk factors for sudden cardiac arrest in coronary artery disease patients

  This study is trying to find out what clinical and genetic factors might increase the risk of sudden cardiac arrest in people with coronary artery disease.

  Recruiting Tampere Heart Hospital · Tampere, Pirkanmaa · NCT06804499

• Genetic assessment of young athletes who experience sudden cardiac arrest during sports

  This study looks at young athletes aged 12 to 35 who have had sudden cardiac arrest during sports to see if genetic factors played a role and to help prevent similar events in others.

  Recruiting at 15 sites Rennes University Hospital · Nîmes, France and 25 other locations · NCT06642168

• Drone-delivered AEDs for cardiac arrests in rural areas

  This project tests whether delivering AEDs by emergency drones to out-of-hospital cardiac arrest sites can reach patients faster than current first responders and EMS in rural communities.

  Recruiting Duke University · Clemmons, North Carolina · NCT06229418

• Registry for HeartStart HS1 Defibrillator performance and safety

  This study looks at how well the HeartStart HS1 Defibrillator works and keeps people safe after they have a suspected heart attack.

  Recruiting Heartstream US LLC · Pittsburgh, Pennsylvania · NCT04840797

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.